Search

Christopher W. Fulton

Examiner (ID: 16699, Phone: (571)272-2242 , Office: P/2855 )

Most Active Art Unit
2855
Art Unit(s)
2859, 3641, 2406, 2899, 2841, 2855, 3108, 2856
Total Applications
3373
Issued Applications
2875
Pending Applications
85
Abandoned Applications
419

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6468041 [patent_doc_number] => 20100040664 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-18 [patent_title] => 'AABB-POLY(DEPSIPEPTIDE) BIODEGRADABLE POLYMERS AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 12/540285 [patent_app_country] => US [patent_app_date] => 2009-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 15317 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20100040664.pdf [firstpage_image] =>[orig_patent_app_number] => 12540285 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/540285
AABB-POLY(DEPSIPEPTIDE) BIODEGRADABLE POLYMERS AND METHODS OF USE Aug 11, 2009 Abandoned
Array ( [id] => 10121350 [patent_doc_number] => 09155696 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-10-13 [patent_title] => 'Pharmaceutical compositions' [patent_app_type] => utility [patent_app_number] => 13/058074 [patent_app_country] => US [patent_app_date] => 2009-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6607 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13058074 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/058074
Pharmaceutical compositions Aug 10, 2009 Issued
Array ( [id] => 6222366 [patent_doc_number] => 20100056432 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-04 [patent_title] => 'TEMPLATE-FIXED PEPTIDOMIMETICS WITH ANTIBACTERIAL ACTIVITY' [patent_app_type] => utility [patent_app_number] => 12/506794 [patent_app_country] => US [patent_app_date] => 2009-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 50251 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0056/20100056432.pdf [firstpage_image] =>[orig_patent_app_number] => 12506794 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/506794
TEMPLATE-FIXED PEPTIDOMIMETICS WITH ANTIBACTERIAL ACTIVITY Jul 20, 2009 Abandoned
Array ( [id] => 11508451 [patent_doc_number] => 09599603 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-03-21 [patent_title] => 'Methods and compositions for modulating adhesion and migration of cadherin expressing cells' [patent_app_type] => utility [patent_app_number] => 12/504578 [patent_app_country] => US [patent_app_date] => 2009-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 13991 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 153 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12504578 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/504578
Methods and compositions for modulating adhesion and migration of cadherin expressing cells Jul 15, 2009 Issued
Array ( [id] => 5315952 [patent_doc_number] => 20090280550 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-12 [patent_title] => 'Polymer-Factor IX Moiety Conjugates' [patent_app_type] => utility [patent_app_number] => 12/499770 [patent_app_country] => US [patent_app_date] => 2009-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 22618 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20090280550.pdf [firstpage_image] =>[orig_patent_app_number] => 12499770 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/499770
Polymer-Factor IX Moiety Conjugates Jul 7, 2009 Abandoned
Array ( [id] => 9777691 [patent_doc_number] => 08852895 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-10-07 [patent_title] => 'Macrocyclic derivative and assemblies formed therefrom' [patent_app_type] => utility [patent_app_number] => 13/002067 [patent_app_country] => US [patent_app_date] => 2009-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 17476 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13002067 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/002067
Macrocyclic derivative and assemblies formed therefrom Jul 5, 2009 Issued
Array ( [id] => 6306384 [patent_doc_number] => 20100069294 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-18 [patent_title] => 'HCV PROTEASE INHIBITORS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/497103 [patent_app_country] => US [patent_app_date] => 2009-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 56701 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20100069294.pdf [firstpage_image] =>[orig_patent_app_number] => 12497103 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/497103
HCV protease inhibitors and uses thereof Jul 1, 2009 Issued
Array ( [id] => 5496339 [patent_doc_number] => 20090264367 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-22 [patent_title] => '5-CNAC AS ORAL DELIVERY AGENT FOR PARATHYROID HORMONE FRAGMENTS' [patent_app_type] => utility [patent_app_number] => 12/495966 [patent_app_country] => US [patent_app_date] => 2009-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3140 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20090264367.pdf [firstpage_image] =>[orig_patent_app_number] => 12495966 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/495966
5-CNAC AS ORAL DELIVERY AGENT FOR PARATHYROID HORMONE FRAGMENTS Jun 30, 2009 Abandoned
Array ( [id] => 5496459 [patent_doc_number] => 20090264487 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-22 [patent_title] => 'HEMIASTERLIN ANALOGS' [patent_app_type] => utility [patent_app_number] => 12/491839 [patent_app_country] => US [patent_app_date] => 2009-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8237 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20090264487.pdf [firstpage_image] =>[orig_patent_app_number] => 12491839 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/491839
HEMIASTERLIN ANALOGS Jun 24, 2009 Abandoned
Array ( [id] => 8177618 [patent_doc_number] => 08178651 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-15 [patent_title] => 'Somatostatin-dopamine chimeric analogs' [patent_app_type] => utility [patent_app_number] => 12/456715 [patent_app_country] => US [patent_app_date] => 2009-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9189 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/178/08178651.pdf [firstpage_image] =>[orig_patent_app_number] => 12456715 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/456715
Somatostatin-dopamine chimeric analogs Jun 21, 2009 Issued
Array ( [id] => 6479844 [patent_doc_number] => 20100092500 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-15 [patent_title] => 'NOVEL IMMUNOGENIC LIPOPEPTIDES COMPRISING T-HELPER AND B-CELL EPITOPES' [patent_app_type] => utility [patent_app_number] => 12/488485 [patent_app_country] => US [patent_app_date] => 2009-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 31389 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20100092500.pdf [firstpage_image] =>[orig_patent_app_number] => 12488485 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/488485
Immunogenic lipopeptides comprising T-helper and B-cell epitopes Jun 18, 2009 Issued
Array ( [id] => 9951135 [patent_doc_number] => 08999923 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-04-07 [patent_title] => 'Heat-stable, aqueous lactoferrin composition and its preparation and use' [patent_app_type] => utility [patent_app_number] => 12/999292 [patent_app_country] => US [patent_app_date] => 2009-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 5312 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12999292 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/999292
Heat-stable, aqueous lactoferrin composition and its preparation and use Jun 14, 2009 Issued
Array ( [id] => 8896887 [patent_doc_number] => 08476408 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-02 [patent_title] => 'Unacylated ghrelin and analogs as therapeutic agents for vascular remodeling in diabetic patients and treatment of cardiovascular disease' [patent_app_type] => utility [patent_app_number] => 12/482882 [patent_app_country] => US [patent_app_date] => 2009-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 14179 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12482882 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/482882
Unacylated ghrelin and analogs as therapeutic agents for vascular remodeling in diabetic patients and treatment of cardiovascular disease Jun 10, 2009 Issued
Array ( [id] => 5484893 [patent_doc_number] => 20090274658 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-05 [patent_title] => 'Tight Junction Modulating Peptides for Enhanced Mucosal Delivery of Therapeutic Compounds' [patent_app_type] => utility [patent_app_number] => 12/480519 [patent_app_country] => US [patent_app_date] => 2009-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15152 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0274/20090274658.pdf [firstpage_image] =>[orig_patent_app_number] => 12480519 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/480519
Tight Junction Modulating Peptides for Enhanced Mucosal Delivery of Therapeutic Compounds Jun 7, 2009 Abandoned
Array ( [id] => 5465114 [patent_doc_number] => 20090325314 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-31 [patent_title] => 'N-Methyl Scanning Mutagenesis' [patent_app_type] => utility [patent_app_number] => 12/479331 [patent_app_country] => US [patent_app_date] => 2009-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3142 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12479331 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/479331
N-Methyl Scanning Mutagenesis Jun 4, 2009 Abandoned
Array ( [id] => 9099810 [patent_doc_number] => 08563689 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2013-10-22 [patent_title] => 'Methods for regulating inflammatory mediators and peptides for useful therein' [patent_app_type] => utility [patent_app_number] => 12/478491 [patent_app_country] => US [patent_app_date] => 2009-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 24 [patent_no_of_words] => 22979 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12478491 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/478491
Methods for regulating inflammatory mediators and peptides for useful therein Jun 3, 2009 Issued
Array ( [id] => 10115737 [patent_doc_number] => 09150609 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-10-06 [patent_title] => 'Process for the preparation of copolymer-1 using a polymer supported dialkylamine initiator' [patent_app_type] => utility [patent_app_number] => 13/375914 [patent_app_country] => US [patent_app_date] => 2009-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 3271 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 214 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13375914 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/375914
Process for the preparation of copolymer-1 using a polymer supported dialkylamine initiator Jun 3, 2009 Issued
Array ( [id] => 8797271 [patent_doc_number] => 08436140 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-05-07 [patent_title] => 'Natriuretic peptide-mediated imaging of atherosclerotic plaque' [patent_app_type] => utility [patent_app_number] => 12/454810 [patent_app_country] => US [patent_app_date] => 2009-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 25 [patent_no_of_words] => 8656 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12454810 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/454810
Natriuretic peptide-mediated imaging of atherosclerotic plaque May 21, 2009 Issued
Array ( [id] => 6120766 [patent_doc_number] => 20110077190 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-31 [patent_title] => 'Selective Caspase Inhibitors and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 12/993565 [patent_app_country] => US [patent_app_date] => 2009-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29793 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20110077190.pdf [firstpage_image] =>[orig_patent_app_number] => 12993565 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/993565
Selective caspase inhibitors and uses thereof May 20, 2009 Issued
Array ( [id] => 7682059 [patent_doc_number] => 20100022749 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-28 [patent_title] => 'Contoxin Analogues and Methods for Synthesizing Same' [patent_app_type] => utility [patent_app_number] => 12/469503 [patent_app_country] => US [patent_app_date] => 2009-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 54693 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20100022749.pdf [firstpage_image] =>[orig_patent_app_number] => 12469503 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/469503
Contoxin analogues and methods for synthesizing same May 19, 2009 Issued
Menu